Anders Fink V.

Anders Fink V. is an accomplished finance professional with extensive experience in executive roles across various companies. Currently serving as the Interim Chief Financial Officer at Minervax ApS, Anders also holds a position as a Non Executive Director at Amplify Therapeutics ApS and consults for Alpha Healthcare Investments ApS and Fink Consult ApS. Previous roles include Chief Executive Officer and Chief Financial Officer at Orphazyme A/S, where significant achievements included managing court restructuring and taking the company public on multiple stock exchanges. Other notable positions held include Chief Executive Officer at Topotarget A/S, Partner & CFO at BankInvest Biomedical Ventures, and Chief Financial Officer at 7TM Pharma. Anders possesses a strong educational background with degrees from Harvard Business School, Copenhagen Business School, University of Melbourne, and Aalborg University, and has a proven track record in financial management, strategic planning, and advisory services.